HER2 Support Group Forums - View Single Post

Rich66 · 06-29-2009, 10:29 AM

I thought it was promising and seemed to be connected to CSCs so I posted a bit on it here:
http://her2support.org/vbulletin/sho...t=39323&page=2
This is much more in depth. I'll add this too.

But...this excerpt from above is bumming me out:
Bert Vogelstein, a leading cancer researcher at Johns Hopkins University, called the method “a creative and promising line of research,” but noted the general odds against success.
“Unfortunately our track record shows that far less than 1 percent of our promising approaches actually make the grade in patients,” he said.

<1%?!! (cough)

And was the methodology flawed?

"researchers had implanted the human tumors under the mice’s skin, a position from which they do not usually spread through the body. So the experiments do not answer the question of whether minicells can attack metastasized cancer,"

06-29-2009, 10:29 AM	#2
Rich66 Senior Member Join Date: Feb 2008 Location: South East Wisconsin Posts: 3,431	I thought it was promising and seemed to be connected to CSCs so I posted a bit on it here: http://her2support.org/vbulletin/sho...t=39323&page=2 This is much more in depth. I'll add this too. But...this excerpt from above is bumming me out: Bert Vogelstein, a leading cancer researcher at Johns Hopkins University, called the method “a creative and promising line of research,” but noted the general odds against success. “Unfortunately our track record shows that far less than 1 percent of our promising approaches actually make the grade in patients,” he said. <1%?!! (cough) And was the methodology flawed? "researchers had implanted the human tumors under the mice’s skin, a position from which they do not usually spread through the body. So the experiments do not answer the question of whether minicells can attack metastasized cancer,"